Tarsus Pharmaceuticals Statistics
Total Valuation
TARS has a market cap or net worth of $3.11 billion. The enterprise value is $2.77 billion.
Important Dates
The next estimated earnings date is Thursday, April 30, 2026, after market close.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TARS has 42.56 million shares outstanding. The number of shares has increased by 11.11% in one year.
| Current Share Class | 42.56M |
| Shares Outstanding | 42.56M |
| Shares Change (YoY) | +11.11% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 3.11% |
| Owned by Institutions (%) | 86.82% |
| Float | 32.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.88 |
| Forward PS | 4.43 |
| PB Ratio | 9.05 |
| P/TBV Ratio | 9.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.85, with a Debt / Equity ratio of 0.24.
| Current Ratio | 3.85 |
| Quick Ratio | 3.72 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.94 |
Financial Efficiency
Return on equity (ROE) is -23.39% and return on invested capital (ROIC) is -12.26%.
| Return on Equity (ROE) | -23.39% |
| Return on Assets (ROA) | -9.45% |
| Return on Invested Capital (ROIC) | -12.26% |
| Return on Capital Employed (ROCE) | -16.64% |
| Weighted Average Cost of Capital (WACC) | 7.56% |
| Revenue Per Employee | $1.22M |
| Profits Per Employee | -$179,508 |
| Employee Count | 370 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 27.18 |
Taxes
In the past 12 months, TARS has paid $2.06 million in taxes.
| Income Tax | 2.06M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +57.13% in the last 52 weeks. The beta is 0.60, so TARS's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +57.13% |
| 50-Day Moving Average | 71.63 |
| 200-Day Moving Average | 61.35 |
| Relative Strength Index (RSI) | 53.36 |
| Average Volume (20 Days) | 677,680 |
Short Selling Information
The latest short interest is 5.46 million, so 12.83% of the outstanding shares have been sold short.
| Short Interest | 5.46M |
| Short Previous Month | 5.81M |
| Short % of Shares Out | 12.83% |
| Short % of Float | 16.89% |
| Short Ratio (days to cover) | 10.24 |
Income Statement
In the last 12 months, TARS had revenue of $451.36 million and -$66.42 million in losses. Loss per share was -$1.59.
| Revenue | 451.36M |
| Gross Profit | 356.35M |
| Operating Income | -70.97M |
| Pretax Income | -64.36M |
| Net Income | -66.42M |
| EBITDA | -69.15M |
| EBIT | -70.97M |
| Loss Per Share | -$1.59 |
Full Income StatementBalance Sheet
The company has $417.27 million in cash and $83.04 million in debt, with a net cash position of $334.23 million or $7.85 per share.
| Cash & Cash Equivalents | 417.27M |
| Total Debt | 83.04M |
| Net Cash | 334.23M |
| Net Cash Per Share | $7.85 |
| Equity (Book Value) | 343.43M |
| Book Value Per Share | 8.07 |
| Working Capital | 387.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.45 million and capital expenditures -$9.86 million, giving a free cash flow of -$22.31 million.
| Operating Cash Flow | -12.45M |
| Capital Expenditures | -9.86M |
| Free Cash Flow | -22.31M |
| FCF Per Share | -$0.52 |
Full Cash Flow StatementMargins
Gross margin is 78.95%, with operating and profit margins of -15.72% and -14.72%.
| Gross Margin | 78.95% |
| Operating Margin | -15.72% |
| Pretax Margin | -14.26% |
| Profit Margin | -14.72% |
| EBITDA Margin | -15.32% |
| EBIT Margin | -15.72% |
| FCF Margin | n/a |
Dividends & Yields
TARS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.11% |
| Shareholder Yield | -11.11% |
| Earnings Yield | -2.14% |
| FCF Yield | -0.72% |
Analyst Forecast
The average price target for TARS is $80.56, which is 10.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $80.56 |
| Price Target Difference | 10.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 24.57% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TARS has an Altman Z-Score of 6.38 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.38 |
| Piotroski F-Score | 3 |
